Acer Therapeutics
(NASDAQ) ACER
This security has been delisted. This page is retained for historical reference.
ACER News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowACER Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
3%
Return on Capital
3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$24.61M
EBITDA
$24.55M
Operating Cash Flow
$30.25M
Capital Expenditure
$171.17K
Free Cash Flow
$30.42M
Cash & ST Invst.
$2.33M
Total Debt
$11.86M
Acer Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$371.79K
N/A
Gross Profit
$287.99K
N/A
Gross Margin
77.46%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
30
N/A
Net Income
$14.73M
-195.3%
EBITDA
$12.88M
-131.6%
Quarterly Fundamentals
Net Cash
$17.56M
-838.5%
Accounts Receivable
$0.00
N/A
Inventory
$5.20M
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$18.15M
+1101.7%
Return on Assets
-2.26%
N/A
Return on Invested Capital
3.36%
N/A
Free Cash Flow
$16.00M
-75.9%
Operating Cash Flow
$16.00M
-76.0%